Kesler Norman & Wride LLC raised its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 87.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,417 shares of the health services provider's stock after acquiring an additional 21,184 shares during the quarter. Kesler Norman & Wride LLC's holdings in Select Medical were worth $758,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. increased its holdings in Select Medical by 0.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,656,320 shares of the health services provider's stock worth $31,222,000 after acquiring an additional 10,000 shares during the period. Raymond James Financial Inc. bought a new position in shares of Select Medical in the 4th quarter worth $5,858,000. Amundi increased its holdings in shares of Select Medical by 183.8% in the 4th quarter. Amundi now owns 52,612 shares of the health services provider's stock worth $985,000 after buying an additional 34,071 shares during the last quarter. Swiss National Bank boosted its stake in shares of Select Medical by 0.7% in the 4th quarter. Swiss National Bank now owns 217,400 shares of the health services provider's stock valued at $4,098,000 after purchasing an additional 1,500 shares in the last quarter. Finally, Vestcor Inc boosted its stake in shares of Select Medical by 16.7% in the 4th quarter. Vestcor Inc now owns 11,055 shares of the health services provider's stock valued at $208,000 after purchasing an additional 1,580 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the stock in a transaction on Monday, May 5th. The shares were acquired at an average price of $15.02 per share, with a total value of $315,420.00. Following the completion of the acquisition, the director directly owned 65,089 shares of the company's stock, valued at $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer directly owned 714,516 shares in the company, valued at $12,861,288. This represents a 23.95% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.60% of the company's stock.
Select Medical Stock Down 2.1%
NYSE SEM traded down $0.32 during trading hours on Tuesday, reaching $14.61. 1,163,039 shares of the company's stock traded hands, compared to its average volume of 993,094. The firm has a market cap of $1.88 billion, a PE ratio of 10.90, a PEG ratio of 0.78 and a beta of 1.32. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.16 and a quick ratio of 1.16. Select Medical Holdings Corporation has a 52-week low of $14.03 and a 52-week high of $40.98. The firm has a 50-day simple moving average of $15.00 and a 200 day simple moving average of $16.90.
Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter in the prior year, the business posted $0.75 earnings per share. The firm's revenue for the quarter was down 24.4% compared to the same quarter last year. Sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.
Select Medical declared that its board has approved a stock repurchase program on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to buy up to 42.6% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its shares are undervalued.
Select Medical Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date was Thursday, May 15th. Select Medical's payout ratio is 18.66%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on SEM shares. Mizuho started coverage on shares of Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price objective for the company. Royal Bank Of Canada dropped their price target on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $26.00.
Get Our Latest Analysis on Select Medical
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.